Tempus AI (TEM) Reports Q3 Loss, Tops Revenue Estimates

Core Insights - Tempus AI reported a quarterly loss of $0.11 per share, better than the Zacks Consensus Estimate of a loss of $0.16, and improved from a loss of $0.25 per share a year ago, resulting in an earnings surprise of +31.25% [1] - The company achieved revenues of $334.21 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 2.38% and significantly up from $180.93 million in the same quarter last year [2] - Tempus shares have increased approximately 162.8% year-to-date, outperforming the S&P 500's gain of 16.5% [3] Earnings Outlook - The future performance of Tempus stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4] - The current consensus EPS estimate for the upcoming quarter is -$0.08 on revenues of $361.46 million, and for the current fiscal year, it is -$0.69 on revenues of $1.26 billion [7] Industry Context - The Medical Info Systems industry, to which Tempus belongs, is currently ranked in the top 24% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - The correlation between near-term stock movements and earnings estimate revisions suggests that tracking these revisions can provide insights into stock performance [5]